Venus Concept Inc.

VERO Nasdaq CIK: 0001409269

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Country Ontario, Canada
Business Address 235 YORKLAND BLVD., TORONTO, , M2J 4Y8
Mailing Address 235 YORKLAND BLVD., TORONTO, , M2J 4Y8
Phone (416) 907-0115
Fiscal Year End 1231
EIN 061681204

Financial Overview

FY2024 FY

$76.35M
Revenue
-$37.25M
Net Income
$93.65M
Total Assets
$2.37M
Stockholders' Equity
$-68.47
EPS

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events February 3, 2026 View on SEC
8-K Current report of material events January 21, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 15, 2026 View on SEC
8-K Current report of material events January 7, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment December 15, 2025 View on SEC
8-K Current report of material events December 2, 2025 View on SEC
10-Q Quarterly financial report November 13, 2025 View on SEC
8-K Current report of material events November 13, 2025 View on SEC
8-K Current report of material events October 31, 2025 View on SEC
4 Insider stock transaction report October 2, 2025 View on SEC

Material Events

8-K Financial Distress February 3, 2026
High Impact
  • Secured an additional $2 million in funding from its primary lender, Madryn Health Partners.
  • Obtained an extension on its loan repayment deadline to February 13, 2024.
View Analysis
8-K Financial Distress January 21, 2026
High Impact
  • Significant annual cost savings (estimated in millions of dollars) from public company compliance.
  • Ability to focus resources on core business, operational efficiency, and product development.
View Analysis
8-K Financial Distress January 7, 2026
High Impact
  • Venus Concept Inc. announced an equity offering to sell new shares, which will result in dilution for existing shareholders.
  • The company secured critical loan agreements with Madryn Health Partners, including waivers on minimum cash requirements for its 'Main Street Priority Loan' until January 14, 2026.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.